Farther Finance Advisors, LLC

Position in IQV — Iqvia Holdings Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in IQV

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$2,099,347

-$339,589 QoQ

Shares Held

12,310

+13.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $17,580,572 across 34 Diagnostics & Research names. IQV ranks #3 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	9,904	$4,868,113
2	DHR	Danaher Corp /De/	18,582	$3,523,147
3	IQV	Iqvia Holdings Inc. This page	12,310	$2,099,347
4	IDXX	Idexx Laboratories Inc /De	2,593	$1,456,980
5	MEDP	Medpace Holdings, Inc.	2,083	$1,000,235
6	LH	Labcorp Holdings Inc.	3,417	$911,689
7	WAT	Waters Corp /De/	1,973	$587,559
8	A	Agilent Technologies, Inc.	5,090	$580,158

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,099,347	12,310	+13.8%	Shares	Sole	2026-04-07
2025-12-31	$2,438,936	10,820	+899.1%	Shares	Sole	2026-01-23
2025-09-30	$205,705	1,083	+172.1%	Shares	Sole	2025-10-14
2025-06-30	$62,720	398	+34.0%	Shares	Sole	2025-07-11
2025-03-31	$52,361	297	-12.6%	Shares	Sole	2025-04-14
2024-12-31	$66,813	340	-16.5%	Shares	Sole	2025-02-10
2024-09-30	$96,446	407	+35.2%	Shares	Sole	2024-10-29
2024-06-30	$63,643	301	+10.3%	Shares	Sole	2024-07-31
2024-03-31	$69,038	273	+16.2%	Shares	Sole	2024-05-14
2023-12-31	$54,374	235	+92.6%	Shares	Sole	2024-02-15
2023-09-30	$24,003	122	+106.8%	Shares	Sole	2023-11-14
2023-06-30	$13,261	59	+47.5%	Shares	Sole	2024-05-14
2023-03-31	$7,955	40	+14.3%	Shares	Sole	2024-05-14
2022-12-31	$7,171	35	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.